Collins confirmation imminent

Francis Collins may be just days away from officially being confirmed to lead the National Institutes of Health, according to Congressional staffers close to the issue. Francis CollinsImage: WikipediaA spokesperson for Senator Mike Enzi (R-WY), who is ranking member of the US Senate Committee on Health, Education, Labor and Pensions, told __The Scientist__ that the committee OKed Collins's nomination without holding a confirmation hearing. The spokesperson, Craig Orfield, said that the committe

Written byBob Grant
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share
Francis Collins may be just days away from officially being confirmed to lead the National Institutes of Health, according to Congressional staffers close to the issue.
Francis Collins
Image: Wikipedia
A spokesperson for Senator Mike Enzi (R-WY), who is ranking member of the US Senate Committee on Health, Education, Labor and Pensions, told __The Scientist__ that the committee OKed Collins's nomination without holding a confirmation hearing. The spokesperson, Craig Orfield, said that the committee performed all the typical vetting, including a criminal background check, a review of past professional history, a financial questionnaire, and a conflicts of interest probe. "Everything checked out to the committee's satisfaction," Orfield said. "If there was a problem of that nature, you can bet that we definitely would have had a confirmation hearing and those issues would have been brought up." Instead, the committee passed Collins's nomination onto the full Senate, and the body is expected to confirm it sometime soon. "I would suspect that it will be a unanimous consent vote," Orfield said. Unanimous consent votes require neither a floor debate nor a roll-call vote, and this one would essentially amount to a proclamation that Collins has been confirmed. But Senate Republicans must agree to the measure before it can be put before the full Senate. A spokesperson from Senate Majority Leader Harry Reid's (D-NV) office, which is in charge of scheduling unanimous consent requests, told __The Scientist__ that Collins's confirmation is imminent. "We are working to get an agreement with Republicans to consider the nomination and hope to do so soon," wrote Reid's deputy communications director Regan Lachapelle in an email.
**__Related stories:__***linkurl:Collins seen as boon to NIH;http://www.the-scientist.com/blog/display/55820/
[9th July 2009]*linkurl:Collins tapped to lead NIH;http://www.the-scientist.com/blog/display/55818/
[8th July 2009]*linkurl:Report: Collins to lead NIH;http://www.the-scientist.com/blog/display/55733/
[26th May 2009]
Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

  • From 2017 to 2022, Bob Grant was Editor in Chief of The Scientist, where he started in 2007 as a Staff Writer. Before joining the team, he worked as a reporter at Audubon and earned a master’s degree in science journalism from New York University. In his previous life, he pursued a career in science, getting a bachelor’s degree in wildlife biology from Montana State University and a master’s degree in marine biology from the College of Charleston in South Carolina. Bob edited Reading Frames and other sections of the magazine.

    View Full Profile
Share
July Digest 2025
July 2025, Issue 1

What Causes an Earworm?

Memory-enhancing neural networks may also drive involuntary musical loops in the brain.

View this Issue
Genome Modeling and Design: From the Molecular to Genome Scale

Genome Modeling and Design: From the Molecular to Genome Scale

Twist Bio 
Screening 3D Brain Cell Cultures for Drug Discovery

Screening 3D Brain Cell Cultures for Drug Discovery

Discover how to streamline tumor-infiltrating lymphocyte production.

Producing Tumor-infiltrating Lymphocyte Therapeutics

cytiva logo
Explore synthetic DNA’s many applications in cancer research

Weaving the Fabric of Cancer Research with Synthetic DNA

Twist Bio 

Products

The Scientist Placeholder Image

Sino Biological Sets New Industry Standard with ProPure Endotoxin-Free Proteins made in the USA

sartorius-logo

Introducing the iQue 5 HTS Platform: Empowering Scientists  with Unbeatable Speed and Flexibility for High Throughput Screening by Cytometry

parse_logo

Vanderbilt Selects Parse Biosciences GigaLab to Generate Atlas of Early Neutralizing Antibodies to Measles, Mumps, and Rubella

shiftbioscience

Shift Bioscience proposes improved ranking system for virtual cell models to accelerate gene target discovery